Ammari, Zaid; Pak, Stella C; Ruzieh, Mohammed; Dasa, Osama; Tiwari, Abhinav; Jaume, Juan C; Alfonso-Jaume, M A
description
Diabetic ketoacidosis (DKA) in patients receiving tacrolimus as part of their immunosuppressive regimen is a rarely reported adverse event. We report a patient with autosomal dominant polycystic kidney disease (ADPKD) and no known history of diabetes mellitus who presented with DKA, 3 months after kidney transplantation.
